|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.540 USD | -0.56% |
|
-8.05% | +3.81% |
| 01-16 | Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly | RE |
| 01-09 | Amazon Pharmacy Begins Offering Wegovy Pill -- Update | DJ |
| Capitalization | 170M 146M 135M 127M 235M 15.61B 252M 1.55B 614M 7.38B 639M 626M 26.95B | P/E ratio 2025 * |
-17x | P/E ratio 2026 * | -10.3x |
|---|---|---|---|---|---|
| Enterprise value | 170M 146M 135M 127M 235M 15.61B 252M 1.55B 614M 7.38B 639M 626M 26.95B | EV / Sales 2025 * |
0.72x | EV / Sales 2026 * | 0.76x |
| Free-Float |
83.76% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: LifeMD, Inc.
More recommendations
More press releases
| 1 day | -0.56% | ||
| 1 week | -8.05% | ||
| Current month | +3.81% | ||
| 1 month | +9.60% | ||
| 3 months | -42.63% | ||
| 6 months | -66.03% | ||
| Current year | +3.81% |
| 1 week | 3.39 |  | 3.88 |
| 1 month | 3.18 | | 4.36 |
| Current year | 3.38 | | 4.36 |
| 1 year | 3.18 | | 15.84 |
| 3 years | 1.14 | | 15.84 |
| 5 years | 1.14 | | 33.02 |
| 10 years | 0.42 | | 33.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shayna Dray
CEO | Chief Executive Officer | 39 | 01/08/2025 |
Marc Benathen
DFI | Director of Finance/CFO | 46 | 01/03/2021 |
Shane Biffar
CMP | Compliance Officer | 43 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Will Febbo
BRD | Director/Board Member | 57 | 20/06/2023 |
John Strawn
CHM | Chairman | 65 | - |
Roberto Simon
BRD | Director/Board Member | 51 | 06/11/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | -8.05% | -31.53% | +98.88% | 170M | |
| +1.60% | +0.40% | -1.48% | +35.27% | 36.12B | |
| -0.52% | -14.02% | -33.82% | +180.64% | 12.6B | |
| -2.28% | -4.87% | -10.04% | +39.09% | 4.71B | |
| +3.07% | +1.38% | - | - | 4.17B | |
| -1.87% | -4.09% | - | - | 2.86B | |
| -0.66% | +7.00% | - | - | 2.81B | |
| +2.89% | -0.47% | +17.64% | -9.86% | 2.27B | |
| -1.71% | -13.86% | +9.59% | - | 1.45B | |
| Average | -0.00% | -4.32% | -8.27% | +68.80% | 7.46B | |
| Weighted average by Cap. | +0.75% | -3.36% | -8.35% | +66.75% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 237M 202M 188M 176M 327M 21.68B 350M 2.16B 853M 10.25B 888M 870M 37.43B | 224M 192M 178M 167M 309M 20.52B 331M 2.04B 808M 9.7B 840M 823M 35.43B |
| Net income | -7.89M -6.75M -6.27M -5.88M -10.9M -723M -11.67M -71.91M -28.46M -342M -29.6M -29M -1.25B | -14.91M -12.75M -11.83M -11.1M -20.59M -1.37B -22.04M -136M -53.73M -645M -55.9M -54.76M -2.36B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
306
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/01/26 | 3.540 $ | -0.56% | 1,060,854 |
| 20/01/26 | 3.560 $ | -5.57% | 765,889 |
| 16/01/26 | 3.770 $ | 0.00% | 879,710 |
| 15/01/26 | 3.770 $ | -2.08% | 705,768 |
| 14/01/26 | 3.850 $ | -3.27% | 1,176,364 |
Delayed Quote Nasdaq, January 22, 2026 at 12:00 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3.540USD
Average target price
9.250USD
Spread / Average Target
+161.30%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LFMD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition